Back to search

Article

Lipidomics reveals biomarkers of the efficacy of first-line ICIs therapy combined with chemotherapy in NSCLC

2024-12-26

Abstract excerpt

<title>Abstract</title> <p>Immune checkpoint inhibitors (ICIs) plus chemotherapy have become the first-line standard therapy for patients with the gene-negative advanced non-small cell lung cancer (NSCLC). There is a lack of reliable biomarkers to predict treatment outcomes. This study aimed to identify relevant lipids that can predict treatment outcomes in NSCLC patients receiving first-line ICIs plus chemothera...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7e025140-9836-598c-b63e-4567c73d2c01
DOI
10.21203/rs.3.rs-5662148/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lipidomics reveals biomarkers of the efficacy of first-line ICIs therapy combined with chemotherapy in NSCLCDOI 10.21203/rs.3.rs-5662148/v1
Select a neighboring publication to make it the new centre.